Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 11 (BNIP3P11)

Target
BNIP3P11
Molecular classification
Other
01

Overview

BCL2 interacting protein 3 pseudogene 11 (BNIP3P11) is annotated as a pseudogene, meaning it does not encode a functional protein product. It is related in sequence to the functional gene *BNIP3* (BCL2 interacting protein 3), a pro-apoptotic member of the BCL-2 family involved in cell death and autophagy, but BNIP3P11 itself lacks evidence of coding potential or biological activity. Consistent with the characteristics of pseudogenes, BNIP3P11 is not considered a therapeutic target, has no known relevant disease associations, drug interactions, or diagnostic value[2]. Key notes: - BNIP3P11 is differentiated from the functional gene *BNIP3*, which is involved in apoptosis and autophagy and is recognized as a potential cancer and cell death target[5][7]. - BNIP3P11 is classified as a *processed pseudogene* in public databases and not a protein or functional molecule[2]. - There is no evidence that BNIP3P11 encodes a protein or displays any therapeutic potential. If you intended to refer to the functional gene *BNIP3* (BCL2/adenovirus E1B 19kDa interacting protein 3), further information can be provided about that target. But as stated, BNIP3P11 is not a functional molecule or target[2].

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 11BNIP3P11

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 11 (BNIP3P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 11 (BNIP3P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call